| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/16/2006 | US7045604 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 05/16/2006 | US7045598 Recombinant infectious laryngotracheitis virus and uses thereof |
| 05/16/2006 | US7045597 Mast cell surface antigen, DNA thereof, and antibody against the antigen |
| 05/16/2006 | US7045596 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 05/16/2006 | US7045576 Adjuvants and copolymer compositions |
| 05/16/2006 | US7045509 Proteins and nucleic acids encoding same |
| 05/16/2006 | US7045508 Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products |
| 05/16/2006 | US7045329 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 05/16/2006 | US7045318 Recombinant fusion proteins to growth hormone and serum albumin |
| 05/16/2006 | US7045314 Method for the production of bacterial toxins |
| 05/16/2006 | US7045313 plasmid containing multiple restriction endonuclease sites comprising a ploypeptide foreign to the vaccina virus or other poxvirus, a virus promoter sequence and a DNA segment from a nonessential regin of the vaccina genome; for expression of the foreign gene after cell or animal infection |
| 05/16/2006 | US7045302 Expressed ligand-vascular intercellular signaling molecule |
| 05/16/2006 | US7045159 Antiviral substances from plant cuticular and epiciticular material |
| 05/16/2006 | US7045136 Methods of immunization using recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences |
| 05/16/2006 | US7045134 Borellia burgdorferi epitope peptides |
| 05/16/2006 | US7045133 VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor |
| 05/16/2006 | US7045132 Comprises nucleotide sequences coding adhesion polypeptides for treating infection; bactericides; genetic vaccines |
| 05/16/2006 | US7045131 For passive immunization of patients infected with or susceptible to infection from Staphylococcus bacteria such as S.aureus and S.epidermidis |
| 05/16/2006 | US7045130 Diagnosis; detection of Dna, Rna |
| 05/16/2006 | US7045129 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3 |
| 05/16/2006 | US7045128 Antibodies against flt3-ligand |
| 05/16/2006 | US7045127 Human anti-epidermal growth factor receptor single-chain antibodies |
| 05/16/2006 | US7045122 Salmonella vaccine |
| 05/16/2006 | CA2129183C Bispecific trigger molecules recognizing lymphocyte antigen cd2 and tumor antigens |
| 05/11/2006 | WO2006050491A2 Methods for antibody engineering |
| 05/11/2006 | WO2006050341A2 Modified streptococcal polysaccharides and uses thereof |
| 05/11/2006 | WO2006050219A2 Broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies |
| 05/11/2006 | WO2006050172A2 Combination cancer immunotherapy with co-stimulatory molecules |
| 05/11/2006 | WO2006050166A2 Methods of preventing and treating rsv infections and related conditions |
| 05/11/2006 | WO2006050155A2 Cancer therapeutic compositions |
| 05/11/2006 | WO2006050116A1 Methods of cancer treatment/prevention using cancer cell-specific surface antigens |
| 05/11/2006 | WO2006050041A2 Methods for reducing or inhibiting brain inflammation or for promoting neurogenesis |
| 05/11/2006 | WO2006048877A2 Treatment of b-cell malignancies with fgfr3 inhibitors |
| 05/11/2006 | WO2006048763A1 Anti-bacterial vaccine compositions |
| 05/11/2006 | WO2006048749A1 Ctla-4 antibody and aromatase inhibitor or combination treatment for breast cancer |
| 05/11/2006 | WO2006048556A1 Citrulline peptides derived from fibrin and recognised by rheumatoid arthritis specific autoantibodies and the use thereof |
| 05/11/2006 | WO2006048295A1 Composition compri sing vlp and amyloid - beta peptide |
| 05/11/2006 | WO2006048174A2 Immunoglobulin fractions |
| 05/11/2006 | WO2006047954A1 The method of obtaining and applying the materials for autoantigen immunological recognition |
| 05/11/2006 | WO2006029887A3 Vaccines comprising plasmodium antigens |
| 05/11/2006 | WO2006027685A3 Glycosylceramide adjuvant for saccharide antigens |
| 05/11/2006 | WO2006014737A3 Growth hormone releasing hormone enhances the immune response induced by vaccination |
| 05/11/2006 | WO2006013472A3 Novel anti-igf-ir antibodies and uses thereof |
| 05/11/2006 | WO2005123141A3 Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent |
| 05/11/2006 | WO2005117977A8 Tissue-specific imaging and therapeutic agents targeting proteins expressed on lung endothelial cell surface |
| 05/11/2006 | WO2005106471A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 4 (ccr4) |
| 05/11/2006 | WO2005095459A3 Monoclonal antibodies to gastrin hormone |
| 05/11/2006 | WO2005092925A3 Immunoglobulin variants outside the fc region |
| 05/11/2006 | WO2005090389A3 Isosteric transformation |
| 05/11/2006 | WO2005082929A3 Beak and feather disease virus sequences, compositions and vaccines and the use thereof in therapy, diagnosis and assays |
| 05/11/2006 | WO2005056764A3 Inhibitors of type 2 vascular endothelial growth factor receptors |
| 05/11/2006 | WO2005047461A3 Polypeptide display libraries and methods of making and using thereof |
| 05/11/2006 | WO2005010023A3 Method for prediction of an epitope |
| 05/11/2006 | WO2004110363A3 Method of inhibiting tumor growth with anti-tissue factor antibodies |
| 05/11/2006 | WO2004042028A3 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
| 05/11/2006 | WO2004032857A3 Antibody therapy |
| 05/11/2006 | WO2002055100A9 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 05/11/2006 | US20060101530 Rors as modifiers of the p21 pathway and methods of use |
| 05/11/2006 | US20060100249 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 05/11/2006 | US20060100152 Methods and compositions in treating pain and painful disorders using 9949, 14230, 760, 62553, 12216, 17719, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 16314, 1613, 1675, 9569 or 13424 molecules |
| 05/11/2006 | US20060100148 Glutathione-S-transferase tag, hexahistidine tag, maltose binding protein tag, haemagglutinin tag, and cellulose binding protein; for treating and preventing Flaviviridae virus (e.g., hepatitis C virus) infections |
| 05/11/2006 | US20060100143 Polypeptide |
| 05/11/2006 | US20060100135 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 05/11/2006 | US20060099658 PCA3, PCA3 genes, and methods of use |
| 05/11/2006 | US20060099635 Anti-GL50 antibodies |
| 05/11/2006 | US20060099568 Signals and molecular species involved in senescence |
| 05/11/2006 | US20060099229 Vibrio cholerae strains VCUSM1 and VCUSM4, method of producing same, and vaccine derivatives thereof |
| 05/11/2006 | US20060099228 Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis |
| 05/11/2006 | US20060099227 Treating a skin wrinkle; reduced toxicity and/or a reduced immunogenicity, storage stability; e.g. hydroxyethyl Starch |
| 05/11/2006 | US20060099226 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 05/11/2006 | US20060099225 Generation of virus-like particles and use as panfilovirus vaccine |
| 05/11/2006 | US20060099224 Methods and compositions concerning poxviruses and cancer |
| 05/11/2006 | US20060099221 Method of screening anti-mycobacterial molecules |
| 05/11/2006 | US20060099220 Antibodies against and methods for producing vaccines for respiratory syncytial virus |
| 05/11/2006 | US20060099219 Mutated hpv-16e7 polypeptide, pharmaceutical composition comprising it and its preparation process |
| 05/11/2006 | US20060099218 Method of strengthening foreign epitope presentation by mhc class i by inhibiting tap activity |
| 05/11/2006 | US20060099217 Inhibiting MHC class I antigen processing by ER aminopeptidase by administering an aminopeptidase inhibitor that is leucine-thiol, lysine-thiol, isoleucine-thiol, bis(1-thio-2-amino-4-methylpentane) diHCL, bis(1-thio-2-amino-3-phenylpropane) diHCL, or an alpha-thiolbestatin and confirming inhibition |
| 05/11/2006 | US20060099216 Peptide delivery |
| 05/11/2006 | US20060099215 Walnut and ryegrass allergens |
| 05/11/2006 | US20060099214 Cancer-linked gene as target for chemotherapy |
| 05/11/2006 | US20060099213 Compositions and methods for homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells |
| 05/11/2006 | US20060099212 treating or preventing a tumor necrosis factor-mediated disease by co-administering methotrexate and a TNF alpha antagonist |
| 05/11/2006 | US20060099211 Safer, more potent human immunoglobulin preparations for treating Alzheimer's disease |
| 05/11/2006 | US20060099210 for screening for modulators for treating mental disorders such as bipolar disorder, schizophrenia and depression; polypeptides; polynucleotides; vectors; host cells |
| 05/11/2006 | US20060099209 prostate and breast carcinoma; used for diagnosis to identify individuals with the high probability of having a malignant disease |
| 05/11/2006 | US20060099208 Method of potentiating the therapeutic action of monoclonal and polyclonal antibodies |
| 05/11/2006 | US20060099207 High affinity antibodies against HMGB1 and methods of use thereof |
| 05/11/2006 | US20060099206 Expression vector comprising gene constructs with deleted sequences; ehnancing heterologous gene expression |
| 05/11/2006 | US20060099205 Bispecific single chain FV antibody molecules and methods of use thereof |
| 05/11/2006 | US20060099204 humanizing a rabbit antibody; to change the amino acid sequence of a CDR without significantly reducing the affinity of the antibody of the antibody |
| 05/11/2006 | US20060099203 B7-DC binding antibody |
| 05/11/2006 | US20060099202 Immunoglobulin construct containing tumor- specific p53bp2 sequenes for eliciting an anti-tumor response |
| 05/11/2006 | US20060099201 Treating a mammal with a formulation comprising an antibody which binds IgE |
| 05/11/2006 | US20060099195 Tumor cells with increased immunogenicity and uses therfor |
| 05/11/2006 | US20060099189 Anti-cancer virus desensitization method |
| 05/11/2006 | US20060099180 Retroviral delivery system |
| 05/11/2006 | US20060099174 Interferon-alpha induced genes |
| 05/11/2006 | US20060099171 Mouse glucocorticoid-induced TNF receptor ligand is costimulatory for T cells |
| 05/11/2006 | US20060099170 Compositions for inducing increased levels of beta-chemokines and methods of use therefor |
| 05/11/2006 | US20060099150 Compositions and methods for the transport of biologically active agents across cellular barriers |